KD Bio Family

- Maximize The Expertise Of Each Company- Share Core Technology- Actualize Drug Candidates Through Clinical TrialsDevelopment and CommercializationJoint DevelopmentSystem- Owns 10 pipeline-related Patents- Developing Cell Penetrating Peptide-Based Drug Delivery Technology- “SynThese™” Platform For The ProductionOf Fully Human Antibody Production

R&D Framework

Commercialize Core Technology

CPP-Based Drug Discovery (Cell Penetrating Peptide) Development of Human Antibody Transformation Platform Technology Molecular Diagnosis KD-MD, Inc (Tentatively named) Prediction/Prevention Adaptive Immune, Inc (Tentatively named) FUTURE PRESENT

Commercialize Core Technology